ArticleTobacco control2026
Characterising 'Spree Bar': an examination of the popularity, marketing and composition of a vaping device with a nicotine analogue across multiple data streams.
Article in Tobacco control, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
backgroundSpree Bar, a line of e-cigarette devices introduced in 2023, leverages 6-methylnicotine (6-MN) as its primary ingredient and is available in nine flavours, each represented by artificial intelligence (AI)-generated avatars.
aimsTo characterise the popularity (via social media analysis and survey data), content (nicotine, nicotine analogues, common flavouring chemicals) and marketing strategy (product avatars and flavour descriptions created by the company on its website and Instagram) of Spree Bar.
resultsPublicly available secondary data (Population Assessment of Tobacco and Health, National Youth Tobacco Survey (NYTS), International Tobacco Control (ITC) Youth survey) have not captured any reported use of Spree Bar. Social media observations revealed little public discussion of Spree Bar, aside from activity surrounding news stories. Chemical analysis confirmed that Spree Bar did not contain nicotine and that the levels of 6-MN were significantly lower than claimed (approximately 0.3% vs 5%). Wilkinson Sword (WS)-23, a synthetic coolant, was present in all varieties, regardless of nominal flavour. Linguistic analysis of Spree Bar promotional text from their novel marketing strategy indicates very little difference in language used across avatars or nominal flavours.
conclusionsThere is limited evidence of widespread uptake of Spree Bar to date. However, its marketing approach and striking mislabeling and coolant ubiquity underscore the need for regulatory vigilance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.